Loading…
Attending this event?
Back To Schedule
Monday, June 17 • 4:45pm - 5:15pm
#158 IT: InSilicoTrials Technologies Innovation Theater: Are Human Patients Needed for Clinical Trials, Tomorrow?

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Component Type: Session

Chart your new horizons by pioneering on the edge of Gen AI-powered In Silico Data Modeling. Proven case studies will be shared in a panel session from regulatory, sponsor and CRO perspectives. Learn how InSilicoTrials has enhanced drug dosing, trial performance, and patient safety across targeted populations. Discover significant reductions in time and costs—achieving up to a 90% efficiency in specific R&D activities—while upholding the highest standards of patient safety.

Don't miss the chance to receive an autographed complimentary copy of the publication "Toward Good Simulation Practice," co-authored by our CEO, Luca Emili, with the contribution of 13+ FDA leaders. This book is a cornerstone in promoting reliable and efficient In Silico Trials solutions, reflecting a major stride in medical research and development.

Chair

InSilicoTrials

Speaker

Moderator
MaryAnne Rizk, PhD

Panelist
Jonathan Solomon Helfgott, MS

Panelist
Luca Emili

Panelist
Adam Kaplin


Speakers
LE

Luca Emili

CEO, InSilicoTrials, United States
Luca Emili is founder & CEO of InSilicoTrials, a platform for modeling and simulation in healthcare & life sciences. He was the CEO of Emaze, a cybersecurity firm specializing in automated security analysis. He holds advisory roles, including at EMA's Cloud Security Consultative Group... Read More →
avatar for Jonathan Helfgott

Jonathan Helfgott

Senior Lecturer, Faculty, & Program Coordinator,, Johns Hopkins University, United States
Jonathan Helfgott is an FDA regulatory, clinical, and market access expert, specializing in medical products’ commercialization. He has overseen global clinical research & regulatory activities such as product development, approvals, clinical trial design & communications with health... Read More →
I
avatar for Adam Kaplin

Adam Kaplin

Chief Scientific and Clinical Innovation Officer, Miralogx, United States
Dr. Adam Kaplin completed his undergrad at Yale and his MD/PhD at Johns Hopkins. He trained with two Nobel Laureates and in Solomon Snyder's lab. Dr. Kaplin was Chief Psychiatric Consultant to the Johns Hopkins Multiple Sclerosis and Transverse Myelitis Centers, researching the immune... Read More →
avatar for MaryAnne Rizk

MaryAnne Rizk

Chief Executive Officer, Rizk Management Advisors, United States
Dr. MaryAnne Rizk builds large-scale partner ecosystems at the intersection of science & technology. A PharmaVoice™ 100 Award Recipient, she champions change and collaboration, accelerating scientific breakthroughs from pipeline to patient. With 25 years in digital transformations... Read More →

Monday June 17, 2024 4:45pm - 5:15pm PDT
Exhibit Hall Theater #1 San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA
  19: InnovationTheaters, Session